(Q38004247)

26 August 2017

Conditioning the whole heart--not just the cardiomyocyte (English)

1 reference

26 August 2017

2

Derek M Yellon

1 reference

26 August 2017

Robert M Bell

1

1 reference

PubMed ID

22521304

26 August 2017

language of work or name

1 reference

11 April 2012

1 reference

Journal of Molecular and Cellular Cardiology

26 August 2017

1 reference

26 August 2017

53

1 reference

26 August 2017

1

1 reference

26 August 2017

24-32

1 reference

Projections of global mortality and burden of disease from 2002 to 2030

26 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Management of the no-reflow phenomenon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

No-reflow phenomenon: maintaining vascular integrity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

No-reflow phenomenon following percutaneous coronary intervention for acute myocardial infarction: incidence, outcome, and effect of pharmacologic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Reperfusion injury salvage kinase and survivor activating factor enhancement prosurvival signaling pathways in ischemic postconditioning: two sides of the same coin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Myocardial reperfusion injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Endogenous cardioprotection by ischaemic postconditioning and remote conditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Mechanism of cardioprotection by early ischemic preconditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Ischemic postconditioning: from receptor to end-effector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

The myocardial JAK/STAT pathway: from protection to failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Role of bradykinin in protection of ischemic preconditioning in rabbit hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Stereological measurement of cellular and subcellular hypertrophy and hyperplasia in the papillary muscle of adult rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Myocardial changes in pressure overload-induced left ventricular hypertrophy. A study on tissue composition, polyploidization and multinucleation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

A novel protective effect of erythropoietin in the infarcted heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Acute erythropoietin cardioprotection is mediated by endothelial response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Reduced capillary density in the myocardium of uremic rats--a stereological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Intercapillary distance and capillary reserve in hypertrophied rat hearts beating in situ

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

The cardiac endothelium: functional morphology, development, and physiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Pretreatment with endothelin-1 mimics ischemic preconditioning against infarction in isolated rabbit heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Endothelin-1 and myocardial preconditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Kinins and cardioprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Characterization of bradykinin B2 receptors in adult myocardium and neonatal rat cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Bradykinin and endothelial-cardiac myocyte interactions in ischemic preconditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Kallidin-like peptide mediates the cardioprotective effect of the ACE inhibitor captopril against ischaemic reperfusion injury of rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

A kallidin-like peptide is a protective cardiac kinin, released by ischaemic preconditioning of rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Participation of prostaglandin E2 in the endothelial protective effect of ischaemic preconditioning in isolated rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Endothelium-derived neuregulin protects the heart against ischemic injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

The contribution of endothelial nitric oxide synthase to early ischaemic preconditioning: the lowering of the preconditioning threshold. An investigation in eNOS knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Arterial blood gases, muscle fiber diameter and intercapillary distance in cardiac hypertrophy of rats with an old myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Diffusion of free nitric oxide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Effects of nitric oxide on mitochondrial permeability transition pore and thiol-mediated responses in cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Inflammatory alterations in the myocardial microcirculation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Vascular dysfunction in ischemia-reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Heme oxygenase and heme degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Induction of heme oxygenase-1 can act protectively against cardiac ischemia/reperfusion in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Carbon monoxide: a vital signalling molecule and potent toxin in the myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Hydrogen sulfide mediates cardioprotection through Nrf2 signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Hydrogen sulfide-mediated myocardial pre- and post-conditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Hydrogen sulfide and ischemia-reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Preconditioning human cardiomyocytes and endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Myocardial and coronary endothelial protective effects of acetylcholine after myocardial ischaemia and reperfusion in rats: role of nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Ischemic preconditioning prevents the impairment of hypoxic coronary vasodilatation caused by ischemia/reperfusion: role of adenosine A1/A3 and bradykinin B2 receptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

The "no-reflow" phenomenon after temporary coronary occlusion in the dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Lessons from human coronary aspirate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Does preconditioning protect the coronary vasculature from subsequent ischemia/reperfusion injury?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Different effects of postconditioning on myocardial no-reflow in the normal and hypercholesterolemic mini-swines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Remote periconditioning reduces myocardial no-reflow by the activation of K ATP channel via inhibition of Rho-kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Erythropoietin: ready for prime-time cardioprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Endogenous serum erythropoietin and no-reflow in patients with ST-elevation myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Effect of erythropoietin as an adjunct to primary percutaneous coronary intervention: a randomised controlled clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Cardiac fibroblast: the renaissance cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Structural and functional coupling of cardiac myocytes and fibroblasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Intracardiac detection of angiotensinogen and renin: a localized renin-angiotensin system in neonatal rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Involvement of cardiotrophin-1 in cardiac myocyte-nonmyocyte interactions during hypertrophy of rat cardiac myocytes in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Cardiac fibroblasts are major production and target cells of adrenomedullin in the heart in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Salicylate or aspirin inhibits the induction of the inducible nitric oxide synthase in rat cardiac fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Expression of heme oxygenase-1 in response to myocardial infarction in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Intramyocardial infusion of FGF-1 mimics ischemic preconditioning in pig myocardium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

High molecular weight FGF-2 promotes postconditioning-like cardioprotection linked to activation of protein kinase C isoforms, as well as Akt and p70 S6 kinases. [corrected].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice mimics ischemic preconditioning through SAPK/JNK1/2 activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Fibroblast growth factor-2 and cardioprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Attenuation of ischemic myocardial injury and dysfunction by cardiac fibroblast-derived factor(s).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Endothelium-targeted overexpression of constitutively active FGF receptor induces cardioprotection in mice myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Fibroblasts and myofibroblasts: what are we talking about?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Ischemic preconditioning protects against gap junctional uncoupling in cardiac myofibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Cell survival signalling in heart derived myofibroblasts induced by preconditioning and bradykinin: the role of p38 MAP kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Effect of preconditioning ischemia on reperfusion arrhythmias after coronary artery occlusion and reperfusion in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

TIMPs and cardiac remodeling: 'Embracing the MMP-independent-side of the family'.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Early measurements of plasma matrix metalloproteinase-2 predict infarct size and ventricular dysfunction in ST-elevation myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Cardioprotection of bradykinin at reperfusion involves transactivation of the epidermal growth factor receptor via matrix metalloproteinase-8.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Cardioprotective growth factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Matrix metalloproteinase-2 degrades the cytoskeletal protein α-actinin in peroxynitrite mediated myocardial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Titin is a target of matrix metalloproteinase-2: implications in myocardial ischemia/reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Hyperlipidemia attenuates the infarct size-limiting effect of ischemic preconditioning: role of matrix metalloproteinase-2 inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Cardiac uptake of minocycline and mechanisms for in vivo cardioprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

All preconditioning-related G protein-coupled receptors can be demonstrated in the rabbit cardiomyocyte.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Cardioprotective effects of adenosine A1 and A3 receptor activation during hypoxia in isolated rat cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte. Involvement of kappa-opioid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Endogenous hydrogen sulfide contributes to the cardioprotection by metabolic inhibition preconditioning in the rat ventricular myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

Ischemic preconditioning upregulates inducible nitric oxide synthase in cardiac myocyte

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.001

10.1016/J.YJMCC.2012.04.001

7 January 2021

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22521304